Efudex and Singulair drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Efudex (fluorouracil) and Singulair (montelukast sodium). Common drug interactions include blood pressure increased among females and basal cell carcinoma among males.

The phase IV clinical study analyzes what interactions people have when they take Efudex and Singulair. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Efudex?

Efudex has active ingredients of fluorouracil. It is often used in actinic keratosis. eHealthMe is studying from 1,391 Efudex users. Check the latest studies of Efudex.

What is Singulair?

Singulair has active ingredients of montelukast sodium. It is often used in asthma. eHealthMe is studying from 129,752 Singulair users. Check the latest studies of Singulair.



On Jul, 08, 2026

36 people who take Efudex and Singulair together, and have interactions are studied.

Efudex and Singulair drug interactions.

What are the common drug interactions of Efudex and Singulair, by gender? *:

female:

  1. Blood pressure increased
  2. Drug hypersensitivity
  3. Headache (pain in head)
  4. Hypoglycaemia (deficiency of glucose in the bloodstream)
  5. Neuropathy peripheral (surface nerve damage)
  6. Pulmonary mass
  7. Raynaud's phenomenon (discoloration of the fingers, toes, and occasionally other areas)
  8. Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)
  9. Vulvovaginal pain
  10. Abdominal discomfort

male:

  1. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  2. Benign neoplasm (benign (non-cancerous) tumour)
  3. Pain
  4. Skin burning sensation
  5. Alcohol abuse
  6. Anaemia (lack of blood)
  7. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  8. Apnoea (suspension of external breathing)
  9. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  10. Arthralgia (joint pain)

What are the common drug interactions of Efudex and Singulair, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Alopecia (absence of hair from areas of the body)
  2. Hair colour changes
  3. Hair disorder

50-59:

  1. Hypergonadism (hyperfunction of the gonads)
  2. Hypertonic bladder (bladder-storage function that causes a sudden urge to urinate)
  3. Lipodystrophy acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired)
  4. Major depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings)
  5. Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
  6. Pain
  7. Spinal pain (pain in spine)
  8. Thyroid mass
  9. Visual impairment
  10. Surgery

60+:

  1. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  2. Benign neoplasm (benign (non-cancerous) tumour)
  3. Dehydration (dryness resulting from the removal of water)
  4. Fall
  5. Skin burning sensation
  6. Abdominal discomfort
  7. Alcohol abuse
  8. Alopecia (absence of hair from areas of the body)
  9. Anaemia (lack of blood)
  10. Anhedonia (inability to experience pleasure from activities usually found enjoyable)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 11 people, 30.56%
  2. Multiple Myeloma (cancer of the plasma cells): 5 people, 13.89%
  3. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 5 people, 13.89%
  4. Pain: 3 people, 8.33%
  5. Insomnia (sleeplessness): 2 people, 5.56%
  6. Immunodeficiency Common Variable: 2 people, 5.56%
  7. Breast Cancer Metastatic: 2 people, 5.56%
  8. Breast Cancer Female: 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Efudex and Singulair?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Efudex and Singulair:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Efudex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Singulair:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Efudex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Singulair and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on fluorouracil and montelukast sodium (the active ingredients of Efudex and Singulair, respectively), and Efudex and Singulair (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: